Grail GRAL 深 沪
等待开盘 10-07 09:30:00 美东时间
139.6773
-14.403
-9.35%
华盛通- 最 高166.475
- 今 开159.43
- 成交量 126.44万股
- 最 低 73.46
- 昨 收 154.08
- 总市值 0
- 52周最高 166.475
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.00
- 委 比 27.34%
- 总股本 --
- 历史最高 166.475
- 量 比 2.64
- 振 幅 60.37%
- 历史最低 0.00
- 每 手 1
- 风险率 20.53%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多FDA Panel Endorses GRAIL Galleri Cancer Screening Tool
The FDA advisory committee voted in favor of GRAIL's Galleri multi-cancer early detection test, moving it closer to official approval.
09-25 01:27
Grail, Epic Plan Galleri Test Integration For 450 Health Systems
GRAIL stock rises after Epic partnership expands Galleri test access; trial shows Stage IV reduction trend despite missing primary endpoint.
04-08 19:40
5 Analysts Assess GRAIL: What You Need To Know
In the last three months, 5 analysts have published ratings on GRAIL (NASDAQ:GR...
02-21 06:00
Why Grail Stock Is Sinking Friday
GRAIL (NASDAQ: GRAL) shares plunged after the NHS-Galleri trial failed to meet its primary endpoint. Explore the trial results.
02-20 18:18
Earnings Scheduled For February 19, 2026
Companies Reporting Before The Bell • Deere (NYSE:DE) is expected to report qua...
02-19 19:11
Beyond The Numbers: 4 Analysts Discuss GRAIL Stock
Analysts' ratings for GRAIL (NASDAQ:GRAL) over the last quarter vary from bulli...
01-27 05:00
GRAIL宣布进行3.25亿美元的股票发行
美股周一早盘，生物科技公司GRAIL（GRAL）股价大涨23%，此前该公司宣布进行3.25亿美元的股票发行，以资助其商业和报销活动。公司预计此次募资加之三星的1.1亿美元投资将支持其运营至2030年。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
2025-10-20 21:59
癌症早筛公司Grail更新2025年现金消耗指引
癌症早筛公司Grail（GRAL）更新2025年现金消耗指引至3.1亿美元，主要由于其Galleri检测产品采用率提升及合作伙伴关系扩展。得益于检测订单增长，该公司报告净亏损同比改善93%。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
2025-08-13 22:29
European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine
Provider of DNA sequencing and array-based technologies, Illumina, Inc. (NASDAQ:ILMN) said it welcomes the European Court of Justice’s (ECJ’s) judgment ruling that the European Commission did not have jurisdiction over Illumina’s acquisition of GRAIL. The judgment confirms Illumina’s longstanding vi...
2024-09-03 21:48
